BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3767)

  • 1. [Effects of adrenergic blockade on adipose tissue lipolysis provoked in cats and humans by intravenous perfusion of isoprenaline].
    Ashford A
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3265-7. PubMed ID: 3767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
    Gibbons DO; Lant AF; Ashford A; Collins RF; Pinder S
    Br J Clin Pharmacol; 1976 Feb; 3(1):177-84. PubMed ID: 973938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].
    Constantin M; Beaughard M; Piris P; Labrid C
    J Pharmacol; 1981; 12(3):239-54. PubMed ID: 6116833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 5. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog].
    Berlan M
    C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of acebutolol].
    Collins RF
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3223-8. PubMed ID: 768905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oestradiol on catecholamine-stimulated lipolysis.
    Lincová D; Miseková D; Elisová K; Wenke M
    Physiol Bohemoslov; 1984; 33(4):342-52. PubMed ID: 6484025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of metabolic adrenoceptors.
    Loakpradit T; Lockwood R
    Br J Pharmacol; 1977 Jan; 59(1):135-40. PubMed ID: 13899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.
    Frisk-Holmberg M; Ostman J
    J Pharmacol Exp Ther; 1977 Mar; 200(3):598-605. PubMed ID: 15099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of acebutolol, an adrenergic beta receptor blocker, on plasma free fatty acids fluctuations caused by isoproterenol administration].
    Nishihara K; Suzuki Y; Kobayashi A; Abe N; Kanagawa T
    Kokyu To Junkan; 1983 Nov; 31(11):1167-71. PubMed ID: 6145198
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
    Traunecker W
    Arzneimittelforschung; 1985; 35(1A):376-82. PubMed ID: 2859032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic beta-blocking potency (pA2) and partial agonist activity of propranolol, practolol, sotalol and acebutolol.
    Lewis MJ; Grey AC; Henderson AH
    Eur J Pharmacol; 1982 Dec; 86(1):71-6. PubMed ID: 6130956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
    Hamada Y; Sato I; Ito K; Kuwabara S; Kojima Y
    Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of propranolol and acebutolol on isoprenaline-induced changes in heart rate and peripheral blood flow in man.
    Mougeot G; Hugues FC; Julien D; Marche J
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):116-25. PubMed ID: 7259364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U; Nürnberger H; Femmer K
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.